Vor Biopharma Inc.(VOR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VOR Vor Biopharma Inc.

交易中 02-10 11:38:53 EST

14.51

+1.34

+10.17%

最高14.59	最低12.94	成交量48.21万
今开13.30	昨收13.17	日振幅12.56%
总市值6.02亿	流通市值2.75亿	总股本4,152万
成交额674.48万	换手率2.54%	流通股本1,897万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VOR","market":"US","secType":"STK","nameCN":"Vor Biopharma Inc.","latestPrice":14.51,"timestamp":1770741528396,"preClose":13.17,"halted":0,"volume":482129,"delay":0,"changeRate":0.10174639331814729,"floatShares":18971400,"shares":41519800,"eps":-386.86,"marketStatus":"交易中","change":1.34,"latestTime":"02-10 11:38:53 EST","open":13.3,"high":14.5941,"low":12.94,"amount":6744818.6165595,"amplitude":0.125596,"askPrice":14.58,"askSize":100,"bidPrice":14.42,"bidSize":397,"shortable":3,"etf":0,"ttmEps":-386.86,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":13.17,"preHourTrading":{"tag":"盘前","latestPrice":13.3243,"preClose":13.17,"latestTime":"09:28 EST","volume":12973,"amount":171423.379834,"timestamp":1770733701161,"change":0.1543,"changeRate":0.011716,"amplitude":0.023569},"postHourTrading":{"tag":"盘后","latestPrice":13.17,"preClose":13.17,"latestTime":"19:32 EST","volume":6319,"amount":83189.05,"timestamp":1770683533370,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.639306,"impliedVol":1.3167,"impliedVolPercentile":0.5033},"requestUrl":"/m/hq/s/VOR/tweets","defaultTab":"tweets","newsList":[{"id":"1175976028","title":"Vor Biopharma Inc.任命Ra Capital的Andrew Levin医学博士及Forbion的Wouter Joustra为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1175976028","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175976028?lang=zh_cn&edition=full","pubTime":"2025-12-24 05:02","pubTimestamp":1766523775,"startTime":"0","endTime":"0","summary":"Vor Biopharma Inc.任命Ra Capital的Andrew Levin医学博士及Forbion的Wouter Joustra为董事会成员","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"1172598054","title":"Vor Biopharma Inc. - 在对成人IgA肾病评估Telitacicept的三期临床研究A阶段中达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1172598054","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172598054?lang=zh_cn&edition=full","pubTime":"2025-11-09 00:48","pubTimestamp":1762620491,"startTime":"0","endTime":"0","summary":"Vor Biopharma Inc. - 在对成人IgA肾病评估Telitacicept的三期临床研究A阶段中达到主要终点","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"1161096783","title":"Telitacicept在48周中国III期开放标签扩展试验中显示持续疗效及良好安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1161096783","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161096783?lang=zh_cn&edition=full","pubTime":"2025-10-29 23:02","pubTimestamp":1761750130,"startTime":"0","endTime":"0","summary":"Telitacicept在48周中国III期开放标签扩展试验中显示持续疗效及良好安全性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"1108854682","title":"修正-Vor Biopharma Inc. : H.c. Wainwright 将目标价提高至 $55（不是 $52），基于 1拆20 股票回购（澄清目标价已调整）","url":"https://stock-news.laohu8.com/highlight/detail?id=1108854682","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108854682?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:54","pubTimestamp":1761742459,"startTime":"0","endTime":"0","summary":"修正-Vor Biopharma Inc. : H.c. Wainwright 将目标价提高至 $55（不是 $52），基于 1拆20 股票回购（澄清目标价已调整）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"1167290647","title":"Vor Biopharma Inc向SEC提交文件，由现有股东出售最多5100万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1167290647","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167290647?lang=zh_cn&edition=full","pubTime":"2025-09-25 05:00","pubTimestamp":1758747618,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会（SEC）提交的文件显示，Vor Biopharma Inc已提交相关申请，计划由现有股东出售最多5100万股普通股。\n此次股票发售并非由公司直接进行，而是由现有股东通过二级市场出售其持有的股份。该公司已向SEC提交了相应的监管文件，为此次股票出售做好准备工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"1122383513","title":"Vor Biopharma Inc.：Stifel将评级从持有上调至买入，目标价从0.3美元上调至55美元以反映股票分割","url":"https://stock-news.laohu8.com/highlight/detail?id=1122383513","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122383513?lang=zh_cn&edition=full","pubTime":"2025-09-24 18:35","pubTimestamp":1758710125,"startTime":"0","endTime":"0","summary":"Vor Biopharma Inc.：Stifel将评级从持有上调至买入，目标价从0.3美元上调至55美元以反映股票分割","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"1161288797","title":"Vor Bio宣布将在AANEM会议上口头汇报48周中国三期全身性重症肌无力临床研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1161288797","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161288797?lang=zh_cn&edition=full","pubTime":"2025-09-18 04:16","pubTimestamp":1758140175,"startTime":"0","endTime":"0","summary":"Vor Bio宣布将在AANEM会议上口头汇报48周中国三期全身性重症肌无力临床研究结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2565258257","title":"Vor Biopharma Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565258257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565258257?lang=zh_cn&edition=full","pubTime":"2025-09-05 03:24","pubTimestamp":1757013893,"startTime":"0","endTime":"0","summary":"北京时间2025年09月05日03时24分，Vor Biopharma Inc.股票出现异动，股价快速跳水5.00%。截至发稿，该股报1.90美元/股，成交量365.814万股，换手率2.89%，振幅4.75%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Novabay Pharmaceuticals, Inc.、Apollomics Inc C/Wts 01/04/2028 、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Purple Biotech Ltd、Novabay Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃，换手率分别为1736.20%、282.54%、147.06%，振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Apollomics Inc C/Wts 01/04/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为62.31%、51.55%、51.23%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc是一家临床阶段细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905032453a710272b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250905032453a710272b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2558643958","title":"Vor Biopharma Inc.8月11日成交额为991.23万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558643958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558643958?lang=zh_cn&edition=full","pubTime":"2025-08-12 16:08","pubTimestamp":1754986122,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Vor Biopharma Inc.成交额为991.23万美元，成交额较昨日增加137.53%，当日成交量为505.72万股。Vor Biopharma Inc.于2025年8月11日跌3.86%，报1.99美元，该股过去5个交易日跌5.69%，年初至今涨79.28%，过去60日涨1063.74%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|991.23万|137.53%|505.72万|#|2025-08-08|417.31万|14.41%|200.39万|#|2025-08-07|364.75万|0.41%|177.34万|#|2025-08-06|363.27万|-12.70%|173.73万|#|2025-08-05|416.10万|1.87%|188.78万|Vor Biopharma Inc是一家临床阶段细胞治疗公司。公司产品包括VCAR33、Tremcel和骨髓增生异常综合征、Trem-cel+VCAR33治疗系统、VADC45、CD123、CLL1、EMR2。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812164729a6e14b57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812164729a6e14b57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2558509777","title":"Vor Biopharma Inc.8月8日成交额为417.31万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558509777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558509777?lang=zh_cn&edition=full","pubTime":"2025-08-09 16:06","pubTimestamp":1754726778,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Vor Biopharma Inc.成交额为417.31万美元，成交额较昨日增加14.41%，当日成交量为200.39万股。Vor Biopharma Inc.于2025年8月8日涨0.0%，报2.07美元，该股过去5个交易日跌1.43%，年初至今涨86.49%，过去60日涨1193.75%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-08|417.31万|14.41%|200.39万|#|2025-08-07|364.75万|0.41%|177.34万|#|2025-08-06|363.27万|-12.70%|173.73万|#|2025-08-05|416.10万|1.87%|188.78万|#|2025-08-04|408.46万|-18.54%|196.28万|Vor Biopharma Inc是一家临床阶段细胞治疗公司。公司产品包括VCAR33、Tremcel和骨髓增生异常综合征、Trem-cel+VCAR33治疗系统、VADC45、CD123、CLL1、EMR2。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809160621a6dc48da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809160621a6dc48da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2557542819","title":"Vor Biopharma Inc.8月7日成交额为364.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557542819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557542819?lang=zh_cn&edition=full","pubTime":"2025-08-08 16:03","pubTimestamp":1754640190,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Vor Biopharma Inc.成交额为364.75万美元，成交额较昨日增加0.41%，当日成交量为177.34万股。Vor Biopharma Inc.于2025年8月7日跌0.96%，报2.07美元，该股过去5个交易日涨0.0%，年初至今涨86.49%，过去60日涨1096.53%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-07|364.75万|0.41%|177.34万|#|2025-08-06|363.27万|-12.70%|173.73万|#|2025-08-05|416.10万|1.87%|188.78万|#|2025-08-04|408.46万|-18.54%|196.28万|#|2025-08-01|501.40万|-34.87%|246.32万|Vor Biopharma Inc是一家临床阶段细胞治疗公司。公司产品包括VCAR33、Tremcel和骨髓增生异常综合征、Trem-cel+VCAR33治疗系统、VADC45、CD123、CLL1、EMR2。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808170917a6dab06f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808170917a6dab06f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2557153052","title":"Vor Biopharma Inc.8月6日成交额为363.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557153052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557153052?lang=zh_cn&edition=full","pubTime":"2025-08-07 15:56","pubTimestamp":1754553386,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Vor Biopharma Inc.成交额为363.27万美元，成交额较昨日减少12.70%，当日成交量为173.73万股。Vor Biopharma Inc.于2025年8月6日跌4.13%，报2.09美元，该股过去5个交易日跌5.43%，年初至今涨88.29%，过去60日涨1284.11%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-06|363.27万|-12.70%|173.73万|#|2025-08-05|416.10万|1.87%|188.78万|#|2025-08-04|408.46万|-18.54%|196.28万|#|2025-08-01|501.40万|-34.87%|246.32万|#|2025-07-31|769.87万|-6.57%|348.58万|Vor Biopharma Inc是一家临床阶段细胞治疗公司。公司产品包括VCAR33、Tremcel和骨髓增生异常综合征、Trem-cel+VCAR33治疗系统、VADC45、CD123、CLL1、EMR2。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807163520a47a7e31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807163520a47a7e31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2557329978","title":"Vor Biopharma Inc.8月5日成交额为416.10万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557329978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557329978?lang=zh_cn&edition=full","pubTime":"2025-08-06 15:47","pubTimestamp":1754466432,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Vor Biopharma Inc.成交额为416.10万美元，成交额较昨日增加1.87%，当日成交量为188.78万股。Vor Biopharma Inc.于2025年8月5日涨3.32%，报2.18美元，该股过去5个交易日跌7.23%，年初至今涨96.4%，过去60日涨1262.5%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-05|416.10万|1.87%|188.78万|#|2025-08-04|408.46万|-18.54%|196.28万|#|2025-08-01|501.40万|-34.87%|246.32万|#|2025-07-31|769.87万|-6.57%|348.58万|#|2025-07-30|824.03万|-48.99%|366.70万|Vor Biopharma Inc是一家临床阶段细胞治疗公司。公司产品包括VCAR33、Tremcel和骨髓增生异常综合征、Trem-cel+VCAR33治疗系统、VADC45、CD123、CLL1、EMR2。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806161257a6d61d44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806161257a6d61d44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2557365216","title":"Vor Biopharma Inc.8月4日成交额为408.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557365216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557365216?lang=zh_cn&edition=full","pubTime":"2025-08-05 15:44","pubTimestamp":1754379854,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Vor Biopharma Inc.成交额为408.46万美元，成交额较昨日减少18.54%，当日成交量为196.28万股。Vor Biopharma Inc.于2025年8月4日涨0.48%，报2.11美元，该股过去5个交易日跌12.81%，年初至今涨90.09%，过去60日涨293.66%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-04|408.46万|-18.54%|196.28万|#|2025-08-01|501.40万|-34.87%|246.32万|#|2025-07-31|769.87万|-6.57%|348.58万|#|2025-07-30|824.03万|-48.99%|366.70万|#|2025-07-29|1615.55万|-31.10%|657.19万|Vor Biopharma Inc是一家临床阶段细胞治疗公司。公司产品包括VCAR33、Tremcel和骨髓增生异常综合征、Trem-cel+VCAR33治疗系统、VADC45、CD123、CLL1、EMR2。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805160014a6d40466&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805160014a6d40466&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2518806279","title":"Vor Biopharma Inc.盘中异动 急速下挫5.00%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518806279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518806279?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:22","pubTimestamp":1741616539,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时22分，Vor Biopharma Inc.股票出现波动，股价大幅下挫5.00%。截至发稿，该股报0.950美元/股，成交量1.0984万股，换手率0.01%，振幅7.99%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3400.89%、719.71%、414.19%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Biodexa Pharmaceuticals Plc，振幅分别为41.36%、40.24%、39.34%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222219abf30f41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310222219abf30f41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2516608852","title":"Vor Biopharma Inc.盘中异动 早盘股价大跌5.46%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516608852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516608852?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:35","pubTimestamp":1741098917,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时35分，Vor Biopharma Inc.股票出现波动，股价快速下挫5.46%。截至发稿，该股报0.900美元/股，成交量5.9896万股，换手率0.05%，振幅6.10%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1076.47%、1070.68%、423.99%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Ibio, Inc.，振幅分别为23.30%、12.57%、12.01%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223517963945c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223517963945c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2514781403","title":"Vor Biopharma Inc.盘中异动 早盘股价大跌14.32%报0.951美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514781403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514781403?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753064,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Vor Biopharma Inc.股票出现异动，股价急速下跌14.32%。截至发稿，该股报0.951美元/股，成交量3.5882万股，换手率0.03%，振幅5.32%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Anaptysbio, Inc.、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为480.24%、239.11%、55.69%，振幅较大的相关个股有Trevi Therapeutics, Inc.、Enanta Pharmaceuticals, Inc.、Aardvark Therapeutics, Inc.，振幅分别为7.11%、6.58%、6.22%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223104a25800bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223104a25800bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VOR","BK4139"],"gpt_icon":0},{"id":"2514626948","title":"Vor Biopharma Inc.盘中异动 急速下挫5.55%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514626948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514626948?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:21","pubTimestamp":1740601275,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时21分，Vor Biopharma Inc.股票出现波动，股价快速下挫5.55%。截至发稿，该股报1.19美元/股，成交量17.4441万股，换手率0.14%，振幅5.56%。Vor Biopharma Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6817.48%、325.68%、264.02%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为194.07%、81.11%、70.39%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227042115a255441a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227042115a255441a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2514801932","title":"Vor Biopharma Inc.盘中异动 早盘大幅下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514801932?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:00","pubTimestamp":1740499251,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时00分，Vor Biopharma Inc.股票出现异动，股价大幅下跌5.30%。截至发稿，该股报1.25美元/股，成交量11.8788万股，换手率0.10%，振幅6.06%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1208.43%、1099.66%、767.55%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc，振幅分别为224.93%、87.83%、64.05%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226000051abdc93c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226000051abdc93c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0},{"id":"2512616571","title":"Vor Biopharma Inc.盘中异动 股价大涨5.47%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512616571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512616571?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:50","pubTimestamp":1739890200,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时50分，Vor Biopharma Inc.股票出现波动，股价快速上涨5.47%。截至发稿，该股报1.45美元/股，成交量8.5405万股，换手率0.07%，振幅3.65%。Vor Biopharma Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Vor Biopharma Inc.公司简介：Vor Biopharma Inc 是一家处于临床阶段的细胞治疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225000988a00d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225000988a00d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VOR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vorbio.com","stockEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":-0.0259},{"period":"3month","weight":0.3384},{"period":"6month","weight":-0.674},{"period":"1year","weight":-0.533},{"period":"ytd","weight":0.0069}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vor Biopharma Inc.于2015年12月30日在特拉华州注册成立为PureTech Health LLC的全资子公司。该公司是一家临床阶段的细胞疗法公司，结合了新颖的患者工程方法和靶向疗法，为患有血液系统恶性肿瘤的患者提供了单一的公司解决方案。该公司的专有平台利用其在造血干细胞生物学，基因组工程和靶向疗法开发方面的专业知识，对HSC进行基因修饰，以去除癌细胞表达的表面靶标。Vor总部位于马萨诸塞州剑桥。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.04043},{"month":2,"riseRate":0.6,"avgChangeRate":-0.014598},{"month":3,"riseRate":0.2,"avgChangeRate":-0.142709},{"month":4,"riseRate":0,"avgChangeRate":-0.179628},{"month":5,"riseRate":0.2,"avgChangeRate":-0.276218},{"month":6,"riseRate":0.4,"avgChangeRate":1.31333},{"month":7,"riseRate":0.2,"avgChangeRate":-0.043439},{"month":8,"riseRate":0.4,"avgChangeRate":0.001368},{"month":9,"riseRate":0.4,"avgChangeRate":-0.0543},{"month":10,"riseRate":0.6,"avgChangeRate":-0.046096},{"month":11,"riseRate":0.2,"avgChangeRate":-0.192554},{"month":12,"riseRate":1,"avgChangeRate":0.3146}],"exchange":"NASDAQ","name":"Vor Biopharma Inc.","nameEN":"Vor Biopharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vor Biopharma Inc.(VOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vor Biopharma Inc.(VOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vor Biopharma Inc.,VOR,Vor Biopharma Inc.股票,Vor Biopharma Inc.股票老虎,Vor Biopharma Inc.股票老虎国际,Vor Biopharma Inc.行情,Vor Biopharma Inc.股票行情,Vor Biopharma Inc.股价,Vor Biopharma Inc.股市,Vor Biopharma Inc.股票价格,Vor Biopharma Inc.股票交易,Vor Biopharma Inc.股票购买,Vor Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vor Biopharma Inc.(VOR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vor Biopharma Inc.(VOR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}